Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

Cardiovascular and Metabolic Disorders

Inclisiran Approval Held Up by Inspection-Related Issues

Diana Ernst, RPh

December 24, 2020

Inclisiran is a chemically synthesized small interfering RNA that targets proprotein convertase subtilisin-kexin type 9 (PCSK9) messenger RNA.

Thyroid

Tepezza Supply Shortage Expected Soon

Diana Ernst, RPh

December 23, 2020

As both the vaccine and Tepezza are being manufactured at Catalent, the government has prioritized the manufacturing of the vaccine thereby resulting in cancellation of previously contracted Tepezza orders.

Diabetes

Sitagliptin Label Change: No Improved Glycemic Control in Pediatric T2D

Diana Ernst, RPh

December 10, 2020

The alert was based on data from three 20-week double-blind, placebo-controlled studies each with 34-week extensions.

Diabetes

Additional Insulin Glargine Now Available in the United States

Diana Ernst, RPh

September 3, 2020

The long-acting human insulin analogue has an identical amino acid sequence to Lantus® (insulin glargine; Sanofi).

General Endocrinology

ACIP: Influenza Vaccination Recommendations for 2020-2021

Diana Ernst, RPh

August 25, 2020

Influenza vaccination should occur by the end of October, if possible.

General Endocrinology

FDA: Risk for Methanol Toxicity With Certain Hand Sanitizers

Diana Ernst, RPh

July 24, 2020

Hand sanitizers containing methanol, or wood alcohol, present a danger to individuals as the substance can be toxic when absorbed through the skin or life-threatening if ingested.

Diabetes

FreeStyle Libre 2 Cleared for Use in Adults and Pediatric Patients With Diabetes

Diana Ernst, RPh

June 18, 2020

The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes.

Cardiovascular and Metabolic Disorders

Combination Therapy of Bempedoic Acid, Ezetimibe Now Available as Adjunct to Statins

Diana Ernst, RPh

June 10, 2020

Nexlizet (bempedoic acid and ezetimibe; Esperion) is now available for use as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C.

Androgen and Reproductive Disorders

FDA Approves Treatment for Heavy Menstrual Bleeding Due to Uterine Fibroids

Diana Ernst, RPh

June 3, 2020

The FDA has approved Oriahnn™ (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules; AbbVie) for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.